Jason S Tedrow

Title: Jason S Tedrow: A Pioneer in Pharmaceutical Innovations

Introduction

Jason S Tedrow is an accomplished inventor based in Evanston, IL. With a remarkable portfolio of 5 patents, he has made significant contributions to the field of pharmaceuticals, particularly focusing on novel compounds with therapeutic applications.

Latest Patents

Tedrow's recent advancements include innovative methodologies concerning Mcl-1 antagonists. His patent titled "Salt forms and solvates of Mcl-1 antagonists" introduces new crystalline salt and solvate forms of a specific compound, (1S,3'R,6′R,7′S,8′E,11′S,12′R)-6-chloro-7′-methoxy-11′,12′-dimethyl-3,4-dihydro-2H,15′H-spiro[naphthalene-1,22′-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.00]pentacosa[8,16,18,24]tetraen]-15′-one 13′,13′-dioxide (AMG 176). This invention also outlines methods for creating these new forms and their potential applications in treating various diseases and disorders. Another significant patent is related to the "Method for the preparation of thiadiazoles," which details innovative processes for synthesizing protected glyceraldehydes and highlights specifically 3-diooxolanyl-thiadiazoles.

Career Highlights

Throughout his career, Tedrow has been associated with notable companies in the pharmaceutical industry. He has worked at Abbott Laboratories Corporation and Amgen Inc., where he has undertaken projects that have furthered the development of advanced therapies.

Collaborations

Jason has collaborated with talented professionals such as Sean M Mellican and Cathie L Linton. Their combined expertise contributes to the innovative research and development efforts in which they have been involved.

Conclusion

Jason S Tedrow stands out as an influential inventor in the realm of pharmaceutical innovations. His patents not only reflect his expertise and dedication to advancing medical science but also showcase the collaborative spirit of inventors working in tandem to change the landscape of healthcare for the better.